Stuart Schnitt
@SchnittStuart
Followers
3K
Following
465
Media
12
Statuses
502
Professor of Pathology @harvardmed, Chief of Breast Oncologic Pathology @DanaFarber, Senior Pathologist @BrighamWomens, Past President of @theUSCAP #BreastPath
Joined March 2017
RT @ChristineDesme2: Registration is now open for the annual invasive #lobular breast cancer symposium ( which will….
0
23
0
RT @IbexMedAx: A closer look at this #USCAP2024 study, evaluating Ibex’s #AI platform's performance in detecting microinvasive breast carci….
0
3
0
RT @DFCI_BreastOnc: ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer. Read the….
0
9
0
RT @ProfRScolyerMIA: Day 2 post op & feeling much better. Still in #ICU at #RPAH/@SydneyLHD. Op seemed to have gone well. Just waiting on #….
0
51
0
RT @ProfRScolyerMIA: Hi all! Feeling great in neuro ICU at #RPAH/@SydneyLHD. Thanks so much to my friend & colleague Dr Brindha Shivalingam….
0
26
0
RT @chandrajitraut: Celebrating Chris Fletcher’s seminal contributions to #sarcoma care and our @DanaFarber @BrighamWomens sarcoma team….
0
12
0
RT @garyleethompson: Day 75/250 of my "tour" of @BCRFcure funded researchers. sometimes you get a 2-for-1. Dr. Schnitt and Dr. Tung, bo….
bcrf.org
Stuart J. Schnitt has been a BCRF investigator since 2007. Learn more about their BCRF-supported research, impact, and progress so far.
0
4
0
RT @DFCI_BreastOnc: A New View of HER2 Expression | Join Drs. Tarantino, Schnitt and Reis-Filho on March 13 in Person or Online for this @P….
0
14
0
RT @ihartpathology: Patient presents with a 8 mm palpable breast mass. Diagnosis? What is the most common molecular finding for this entity….
0
57
0
RT @AstridWeins: I am deeply honored to announce that I have been appointed to succeed my mentor and teacher, Dr Helmut Rennke, as the next….
0
14
0
RT @stolaney1: Incredible lecture by @LANewmanMD who is dedicated to understanding and improving disparities in care and outcomes we see fo….
0
3
0
RT @OKantorMD: An inspiring talk by @LANewmanMD at the 4th Annual Carolyn Kaelin Visiting Lecture @DFCI_BreastOnc @BrighamSurgery on triple….
0
8
0
RT @EMittendorfMD: @stolaney1 @DrHBurstein @AnnPartridgeMD @nlinmd @elmayermd - our work looking at racial differences in the immune respon….
0
10
0
RT @TariKingMD: Thanks for sharing your work and expertise with us @LANewman - a phenomenal way to resume our Carolyn Kaelin Visiting Profe….
0
1
0
RT @TariKingMD: Looking forward to hosting Dr Lisa Newman @BrighamSurgery and @DFCI_BreastOnc for Carolyn Kaelin visiting Professorship. ht….
0
7
0
RT @DoktoraMalvar: Dr. @SchnittStuart covering Updates on Lobular Carcinoma In Situ Classification and Management … WATCH OUT for invasive….
0
24
0
RT @IbexMedAx: Are you in Basel for #ECP2022? join this talk by Drs. @SchnittStuart @JudithSandbank on practical implications of using #AI….
0
2
0